Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024
2024 · Eurosurveillance · 165 citations
https://doi.org/10.2807/1560-7917.es.2024.29.6.2400046